Skip to main content
. 2022 Aug 24;26(1):69–79. doi: 10.1007/s10123-022-00273-6

Table 3.

Prevalence of SC + in subgroup B1 (affected by GTI) and in subgroup B2 (without GTI) according to the seminal parameters

n SC +  Gram +  Gram −  Gram + / − 
Subgroup B1 n. 285

n. 75/285

(26.3%)

n. 32/75

(42.7%)

n. 25/75

(33.3%)

n. 18/75

(24.0)

  OAT

n. 48/285

(16.8%)

13/48

(27.0%)

n. 5/13

(38.5%)

n. 4/13

(30.8%)

n. 4/13

(30.8%)

  Oligospermic

n. 15/285

(5.3%)

3/15

(20.0%)

n. 2/3

(66.7%)

n. 0/3

(–)

n. 1/3

(33.3%)

  Asthenospermic

n. 96/285

(33.7%) a

36/96

(37.5%)c

16/36

(44.4%)

13/36

(36.1%)

7/36

(19.4%)

  Oligoasthenospermic

n. 98/285

(34.4%) b

19/98

(19.3%)

n. 8/19

(42.1%)

n. 5/19

(26.3%)

n. 6/19

(31.6%)

  Azoospermic

n. 6/285

(2.1%)

1/6

(16.7%)

n. 0/1

(–)

n. 1/1

(100.0%)

n. 0/1

(–)

  Normospermic

n. 22/285

(7.7%)

n. 3/22

(22.7%)

n. 2/3

(66.7%)

n. 1/3

(33.3%)

n. 0/3

(–)

Subgroup B2 n. 193

n. 12/193

(6.2%)

n. 5/12

(41.7%)

n. 4/12

(33.3%)

n. 3/12

(25.0%)

  OAT

n. 13/193

(6.7%)

1/13

(7.6%)

n. 0/1

(–)

n. 1/1

(100.0%)

n. 0/1

(–)

  Oligospermic

n. 16/193

(8.3%)

0/16

(–)

(–) (–) (–)
  Asthenospermic

n. 22/193

(11.4%)

6/22

(27.2%)e

n. 3/6

(50.0%)

n. 1/6

(16.7%)

n. 2/6

(33.3%)

  Oligoasthenospermic

n. 24/193

(12.4%)

4/24

(24.3%)

n. 2/4

(50.0%)

n. 1/4

(25.0%)

n. 1/4

(25.0%)

  Azoospermic

n. 6/193

(3.1%)

0/6

(–)

(–) (–) (–)
  Normospermic

n. 112/193

(58.1%) d

1/112

(0.9%)

n. 0/1

(–)

n. 1/1

(100.0%)

n. 0/1

(–)

OAT oligoasthenozoospermic

ap = 0.001 vs. normospermic, oligozoospermic, OAT and azoospermic Subgroup B1

bp = 0.001 vs. normospermic, oligozoospermic, OAT and azoospermic subgroup B1

cp = 0.04 vs. normospermic subgroup B1

dp = 0.0001 vs. all subgroup B2

ep = 0.0001 vs. normospermic vs. subgroup B2